Combining BeEAM with Brentuximab Vedotin for High-Dose Therapy in CD30 Positive Lymphomas before Autologous Transplantation-A Phase I Study.

Rausch, Christian; Bacher, Ulrike; Rabaglio, Manuela; Vorburger, Corinne; Klingenberg, Anke; Banz, Yara; Daskalakis, Michael; Pabst, Thomas.

Afiliación

Rausch C; Department of Medical Oncology, Inselspital, University Hospital Bern, University of Bern, 3010 Bern, Switzerland.
Bacher U; Medical Department III-Hematology and Oncology, Campus Grosshadern, Ludwig Maximilian's University Munich, 81377 Munich, Germany.
Rabaglio M; Department of Hematology, Inselspital, University Hospital Bern, University of Bern, 3010 Bern, Switzerland.
Vorburger C; Department of Medical Oncology, Inselspital, University Hospital Bern, University of Bern, 3010 Bern, Switzerland.
Klingenberg A; Department of Medical Oncology, Inselspital, University Hospital Bern, University of Bern, 3010 Bern, Switzerland.
Banz Y; Department of Medical Oncology, Inselspital, University Hospital Bern, University of Bern, 3010 Bern, Switzerland.
Daskalakis M; Institute of Pathology, University of Bern, 3008 Bern, Switzerland.
Pabst T; Department of Hematology, Inselspital, University Hospital Bern, University of Bern, 3010 Bern, Switzerland.

J Clin Med ; 11(18)2022 Sep 13.

Article en En | MEDLINE | ID: mdl-36143025